Erlotinib therapy in non small cell lung cancer patients-survival of "poor prognosis patients"

Pešek, Miloš; Krejčí, Jana; Skřičková,  Jana; Zatloukal, Petr; Kolek, Vítězslav; Salajka, Vítěslav; Koubková, Leona; Dimka, Sixtová; Petruželka, Luboš; Roubec, Jaromír; Vyzula, Rostislav; Pavlík,  Tomáš

Erlotinib therapy in non small cell lung cancer patients-survival of "poor prognosis patients"

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	PEŠEK Miloš KREJČÍ Jana SKŘIČKOVÁ Jana ZATLOUKAL Petr KOLEK Vítězslav SALAJKA Vítěslav KOUBKOVÁ Leona DIMKA Sixtová PETRUŽELKA Luboš ROUBEC Jaromír VYZULA Rostislav PAVLÍK Tomáš
Year of publication	2009
Type	Article in Periodical
Magazine / Source	Journal of Thoracic Oncology
MU Faculty or unit	Faculty of Medicine
Citation
Field	Pneumology
Keywords	non small cell lung cancer; erlotinib; treatment of "poor prognosis" patients
Description	"Poor prognosis" NSCLC patients were treated with erlotinib and their survival of evaluated. Erlotinib therapy in non small cell lung cancer patients-survival of "poor prognosis patients"
Related projects:	Environment - carcinogenesis - oncology